Publications:253
- Home
- Profiles
Video Visit Available
Accepting New Patients
Mount Sinai DoctorsTreats Adults
Video Visit Available
Accepting New PatientsJaime Uribarri, MD
Nephrology
Department of Medicine-Renal Medicine
212-241-4060
- About Me
- Clinical Focus
- Video
- Education & Certifications
- Research
- Locations
- Insurance
- Publications
- Patient Experience Rating
- Industry Relationships
About Me
Language
Position
Hospital Affiliations
- The Mount Sinai Hospital
About Me
Language
Position
Hospital Affiliations
- The Mount Sinai Hospital
Clinical Focus
- Alkalosis
- Amyloidosis
- Blood Vessel Inflammation / Vasculitis
- Chronic Kidney Disease
- Dialysis
- Glomerulonephritis
- Hyperkalemia
- Hypernatremia
- Hypokalemia
Show More
- Alkalosis
- Amyloidosis
- Blood Vessel Inflammation / Vasculitis
- Chronic Kidney Disease
- Dialysis
- Glomerulonephritis
- Hyperkalemia
- Hypernatremia
- Hypokalemia
- Hyponatremia
- Kidney Biopsy
- Kidney Stones
- Kidney Transplant
- Membranous Nephropathy
- Multiple Myeloma
- Nephritis
- Nephrotic Syndrome
- Peritoneal Dialysis
- Polycystic Kidney Disease
Video
Education
MD, Universidad de Chile, Facultad De Medicina
Residency, Internal Medicine
Brooklyn Hospital-Caledonian Hospital
Residency, Internal Medicine
Brooklyn Hospital-Caledonian Hospital
Fellowship, Nephrology
SUNY Downstate Medical Center
Certifications
American Board of Internal Medicine
Research
Serum levels of advanced glycoxidation end products (AGE) are elevated in diabetes, renal failure and advanced age and these compounds are thought to mediate, at least in part, many of the vascular complications associated with these conditions. AGEs are a heterogeneous group of compounds formed from the non-enzymatic reaction of reducing sugars with the free amino groups of proteins. It had been assumed that circulating AGE originate exclusively from endogenous sources but now it has become clear that foods contain a variable amount of pre-formed AGE and AGE-precursors that contribute to the body AGE pool.We have recently demonstrated that serum AGE levels correlate with dietary AGE content in ESRD patients on dialysis. When a subgroup of these patients was randomized to follow a diet low in AGE content for 4 weeks, we observed 30% of decrease of serum AGE levels and parallel changes in CRP levels. These studies suggest that dietary AGEs play an important role in determining the body AGE pool and that dietary AGE modulation is a feasible, safe and effective way to decrease body AGE pool. Our working hypothesis is that AGEs represent independent risk factors for cardiovascular disease in renal failure patients. Our next research phase will try to demonstrate in a larger number of patients that low AGE diet can reduce serum AGE levels and at the same time improve the direct markers of vascular structure and function: brachial artery dilatation in response to hyperemia and arterial stiffness.
Other areas of research interest include:
Locations
Insurance Information
Accepted insurance may vary by the doctor’s office location. Please contact the office directly to obtain the most up-to-date insurance information.
Patients with Healthfirst Medicare Advantage insurance: Effective , Mount Sinai’s primary care providers (internal medicine, family practice, and geriatrics) are not accepting new Healthfirst Medicare patients. Please contact Healthfirst for help finding a primary care provider. Healthfirst Medicare members who have a relationship with a Mount Sinai primary care provider can continue to book appointments with them.
- Department of Medicine-Renal Medicine5 East 98th Street, 11th Floor, New York, NY, 10029
- 1199 SEIU
- AETNA - Commercial
- AETNA - Medicare
- Affinity Medicaid-Medicare-Essential Exchange
- Amidacare Medicaid
- CIGNA Healthcare
- Centivo
- Cigna - Medicare
- Elderplan
- EmblemHealth - GHI-PPO
- EmblemHealth - HIP
- EmblemHealth - HIP-Medicaid
- EmblemHealth - HIP-Medicare
- Empire Blue Cross Blue Shield - Commercial/Exchange
- Empire Blue Cross Blue Shield - HealthPlus Medicaid
- Empire Blue Cross Blue Shield - Medicare
- Fidelis Health Care
- HealthFirst Medicaid
- HealthFirst Medicare
- Horizon NJ
- Hotel Trades
- Humana Medicare
- Magnacare-Health Care
- Medicare - NJ
- Medicare - NY
- Metroplus
- Multiplan PHCS
- NJ Medicaid
- NY Medicaid
- Oscar
- Oxford - Freedom and Liberty
- Partners Health Plan
- Senior Whole Health
- United Health Care - Commercial
- United Health Care - Empire Plan
- United Health Care - Oxford Care
- United Health Care - Top Tier
- VNSNY Choice Medicare
- VNSNY Select Health Medicaid
- VillageCareMax
- WellCare Health Plan
Physicians who provide services at hospitals and facilities in the Mount Sinai Health System might not participate in the same health plans as those Mount Sinai hospitals and facilities (even if the physicians are employed or contracted by those hospitals or facilities).
Information regarding insurance participation and billing by this physician may be found on this page, and can also be obtained by contacting this provider directly. Because physicians insurance participation can change, the insurance information on this page may not always be up-to-date. Please contact this physician directly to obtain the most up-to-date insurance information.
Insurance and health plan networks that the various Mount Sinai Health System hospitals and facilities participate in can be found on the Mount Sinai Health System website.
Publications
Selected Publications
- Modulation of circulating levels of advanced glycation end products and its impact on intima-media thickness of both common carotid arteries: CORDIOPREV randomised controlled trial. Francisco M. Gutierrez-Mariscal, Alejandro Lopez-Moreno, Jose D. Torres-Peña, Purificacion Gomez-Luna, Antonio P. Arenas-de Larriva, Juan Luis Romero-Cabrera, Raul M. Luque, Jaime Uribarri, Pablo Perez-Martinez, Javier Delgado-Lista, Elena M. Yubero-Serrano, Jose Lopez-Miranda. Cardiovascular Diabetology
- Impact of Prior Abdominal Procedures on Peritoneal Dialysis Catheter Outcomes: Findings From the North American Peritoneal Dialysis Catheter Registry. Wazaira A. Khan, Matthew J. Oliver, John H. Crabtree, Alix Clarke, Sean Armstrong, Danielle Fox, Rachel Fissell, Arsh K. Jain, Sarbjit V. Jassal, Susie L. Hu, Peter Kennealey, Scott Liebman, Brendan McCormick, Bogdan Momciu, Robert P. Pauly, Beth Pellegrino, Jeffrey Perl, James L. Pirkle, Troy J. Plumb, Pietro Ravani, Rebecca Seshasai, Ankur Shah, Nikhil Shah, Jenny Shen, Gurmukteshwar Singh, Karthik Tennankore, Jaime Uribarri, Murray Vasilevsky, Robert Yang, Robert R. Quinn. American Journal of Kidney Diseases
- Performance Evaluation of an Automated Peritoneal Dialysis Solution Generation System in Patients Using Automated Peritoneal Dialysis. Shuchita Sharma, Osama E. Shamy, Alyssa Wilmington, Brad Keller, Nabeel Aslam, Ha Tran, Peter Rutherford, Jaime Uribarri. Kidney International Reports
Patient Experience Rating
The Patient Experience Star Rating reflects our patients’ perception of how well their Mount Sinai provider communicated with them during an office visit. The Star Rating is based on patient responses to three questions on a patient experience survey, a standardized questionnaire sent to verified patients and distributed by a third party vendor, Press Ganey. Responses are measured on a scale of 1 to 5, with 5 being the best score.
Care Provider’s Explanation
4.9 out of 5
Care Provider’s Concern
5 out of 5
Likelihood to Recommend Care Provider
4.7 out of 5
Industry Relationships
Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device, biotechnology companies, and other outside entities to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their outside financial relationships.
Dr. Uribarri has not yet completed reporting of Industry relationships.
Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.
Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device, biotechnology companies, and other outside entities to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their outside financial relationships.
Dr. Uribarri has not yet completed reporting of Industry relationships.
Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.